-
CRISPR-based genome editing of a diurnal rodent, Nile grass rat (Arvicanthis niloticus)
-
Utilization of CRISPR-Cas genome editing technology in filamentous fungi: function and advancement potentiality
-
Abstract 6569: KLIPP: Precision targeting of cancer with CRISPR
-
A Genome Wide CRISPR Profiling Approach Identifies Mechanisms of Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
-
Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications
-
Development and implementation of a Type I-C CRISPR-based programmable repression system for Neisseria gonorrhoeae
-
CRISPR-based Genome Editing of a Diurnal Rodent, Nile Grass Rat (Arvicanthis niloticus)
-
Exploiting Activation and Inactivation Mechanisms in Type I-C CRISPR-Cas3 for Genome Editing Applications
-
KLIPP - a precision CRISPR approach to target structural variant junctions in cancer
-
Keratinocytes sense and eliminate CRISPR DNA through STING/IFN-κ activation and APOBEC3G induction
-
Decoding CRISPR–Cas PAM recognition with UniDesign
-
A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer
-
Abstract 1068: A precision CRISPR approach to target structural variant junctions in cancer
-
Decoding CRISPR–Cas9 PAM recognition with UniDesign
-
Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic
-
CEDA: integrating gene expression data with CRISPR-pooled screen data identifies essential genes with higher expression
-
Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
-
Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic
-
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue
-
Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems
-
Abstract 2037: Targeting chromosome rearrangements in cancer with CRISPR
-
168 STING-IFN-κ-APOBEC3G pathway mediates resistance to CRISPR transfection in keratinocytes
-
276 Autocrine IFN-κ restricts CRISPR-Cas9 Keratinocyte transfection through STING-APOBEC3G activation
-
Inserting DNA with CRISPR
-
CRISPR knockout screen implicates three genes in lysosome function